Details for New Drug Application (NDA): 208021
✉ Email this page to a colleague
The generic ingredient in DICLOFENAC SODIUM is diclofenac sodium; misoprostol. There are forty-seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the diclofenac sodium; misoprostol profile page.
Summary for 208021
Tradename: | DICLOFENAC SODIUM |
Applicant: | Lupin Pharms |
Ingredient: | diclofenac sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 208021
Mechanism of Action | Cyclooxygenase Inhibitors |
Physiological Effect | Decreased Prostaglandin Production |
Suppliers and Packaging for NDA: 208021
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DICLOFENAC SODIUM | diclofenac sodium | SOLUTION;TOPICAL | 208021 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-537 | 68180-537-01 | 1 BOTTLE, PUMP in 1 CARTON (68180-537-01) / 112 g in 1 BOTTLE, PUMP |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 2% | ||||
Approval Date: | Sep 20, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription